Lawmakers urged to lower drug costs

After the U-S House of Representatives passed a bipartisan infrastructure bill late Friday, A-A-R-P is calling on lawmakers to pass the Build Back Better Act, which among other provisions would clear the way for Medicare to negotiate lower prices with drug makers. Tom Lacock with A-A-R-P Wyoming says members have called and emailed Congress more than one-point-five million times this year, with more than 300-thousand emails and nine thousand phone calls in the last few days alone.
“At AARP we really have to thank our members that took the time and made the calls and the emails to Congress. That action shows how important of an issue this is to our membership and all older adults.”
The drug industry has long argued that high profit margins fuel research and development, which has produced significant advances in medicine. But researchers at Memorial Sloan Kettering found that revenues from drug companies’ top 20 medicines pay for all their annual research and development, and still result in a profit of some 40 billion dollars.
 



Jackson Hole Radio